Presentation and Surgical Management of Ischemic Priapism: A 5-Year Review

Crossmark: check for updates

Authors

  • Terkaa Atim Department of Surgery, Division of Urology, University of Abuja Teaching Hospital, Gwagwalada, Nigeria; College of Health Sciences, University of Abuja, Abuja, Nigeria
  • Oseremen Inokhoife Aisuodionoe-Shadrach Department of Surgery, Division of Urology, University of Abuja Teaching Hospital, Gwagwalada, Nigeria; College of Health Sciences, University of Abuja, Abuja, Nigeria
  • Ajibola OH Department of Surgery, Division of Urology, University of Abuja Teaching Hospital, Gwagwalada, Nigeria

DOI:

https://doi.org/10.17140/UAOJ-1-106

Keywords:

Priapism, Sickle cell disease, Shunts, Detumesense

Abstract

Objectives: To review the clinical presentation and surgical interventions carried out on patients with ischemic priapism at a tertiary health facility in north central Nigeria. Patients and Methods: Seventeen patients (median age 17 years, range 4-37) who were managed surgically and reviewed over a 5 year period. All patients had undergone distal shunt procedures and the outcomes on erectile function were examined in those who were sexually active.

Results: Most of the patients presented after 24 hours or more (>24 hours) following the onset of priapism. Sickle Cell Disease constituted 85% of all cases and we noted a bimodal age pattern amongst them (<12 years and >18 years). Intermittent penile massaging was employed after the shunt procedure to maintain detumescense in 12 patients after 24 hours of surgery. Twenty-five percent and 37% of sexually active patients maintained normal and partial erectile function respectively after surgical intervention regardless of delay in presentation.

Conclusion: This review highlights the fact that late and delayed presentation of priapism is still common in our environment and sickle cell disease remains a major predisposition. Appropriate surgical intervention using shunt procedures no matter how late, has the potential to preserve erectile function in some patients.

References

Bochinski DJ, Deng DY, Lue TF. The treatment of priapism-when and how? Int J Impot Res. 2003; 15 Suppl 5: S86-S90. Urology and Andrology – Open Journal.Web site. http://search.proquest.com/openview/9ea086db3d1 3d26973c9ad6048e2fbf1/1?pq-origsite=gscholar&cbl=46833. Accessed March 2, 2017.

Badmus TA, Adediran IA, Adesunkanmi ARK, Katung IA. Priapism in southwestern Nigeria. East Afr Med J. 2003; 80: 518-524. Web site. http://journals.uonbi.ac.ke/files/journals/1/ articles/617/submission/original/617-2289-1-SM.pdf. Accessed March 2, 2017.

Dawam D, Kalayi G, Nmadu PN. Cavernosal spongiosium shunt in the management of priapism in Zaria, Nigeria. Trop Doct. 2000; 30: 31-32. Web site. http://journals.sagepub.com/ doi/abs/10.1177/004947550003000116?journalCode=tdoa. Accessed March 2, 2017.

Adeyoju AB, Olujohungbe AB, Morris J, et al. Priapism in sickle-cell disease; incidence, risk factors and complications-an international multicentre study. BJU Int [Internet]. 2002; 90(9): 898-902. doi: 10.1046/j.1464-410X.2002.03022.x

Aghaji AE. Priapism in adult Nigerians. BJU Int. 2000; 85(4): 493-495. doi: 10.1046/j.1464-410x.2000.00561.x

Anheuser P, Treiyer A, Steffens J. Priapism. Urologe A. 2009; 48: 1105-1112.

Altman AL, Seftel AD, Brown SL, Hampel N. Cocaine associated priapism. J Urol. 1999; 161(6): 1817-1818. doi: 10.1016/S0022-5347(05)68812-X

Tran QT, Wallace RA, Sim EHA. Priapism, ecstasy, and marijuana: Is there a connection? Adv Urol. 2008; 2008: 193694. doi: 10.1155/2008/193694

Van der Horst C, Stuebinger H, Seif C, Melchior D, Martínez-Portillo FJ Juenemann KP. Priapism-etiology, pathophysiology and management. Int Braz J Urol. 2003; 29(5): 391-400. doi:

1590/S1677-55382003000500002

Downloads

Published

2017-03-30

How to Cite

Terkaa Atim, Oseremen Inokhoife Aisuodionoe-Shadrach, & Ajibola OH. (2017). Presentation and Surgical Management of Ischemic Priapism: A 5-Year Review. Urology and Andrology , 1(2), 22–25. https://doi.org/10.17140/UAOJ-1-106